{"AdditionalFields":[{"Key":"AACROrganSiteAll","Value":""},{"Key":"AACRTrackAll","Value":""},{"Key":"CEHoursPP8","Value":""},{"Key":"LivecastUrl","Value":""},{"Key":"RelatedArticlesProgPlan","Value":""},{"Key":"SessionCategoryBasic","Value":""},{"Key":"SessionName","Value":"Meet and Greet"},{"Key":"VideoType","Value":""},{"Key":"WebcastIPSessionLink","Value":""},{"Key":"Presentation Count","Value":"1"}],"BoothSponsorshipIdForCalendar":null,"BoothSponsorshipIdForDetail":null,"BoothSponsorshipIdForResult":null,"CSlideId":null,"Color":null,"ContentCaptureVendorSpecification":null,"Created":null,"Date":"2022-04-12","Description":"Interactive discussion with the Editor-in-Chief of Molecular Cancer Therapeutics about the scope and types of research manuscripts he is seeking to publish in the journal.","Duration":0,"EmbargoSessionContentRule":null,"EmbargoSessionContentUntil":null,"End":"4\/12\/2022 10:30:00 AM","EndTime":"10:30","HidePresentationRating":"False","HidePresentations":"False","Id":"800","Key":"8a9143b2-135b-4a7c-825c-ae722095ecbf","LastUpdated":"2022-03-25 12:18","LimitCMEToRegistrationCodes":null,"LimitMediaToRegistrationCodes":null,"Location":"AACR Publications Booth 2101, Exhibit Halls D-H","MediaSource":"None","MediaSourceDetails":null,"MediaSourceDuration":null,"MediaSourceDurationHMS":null,"Notes":null,"Number":"MG11","OnDemand":"False","OwnerKey":null,"PlayerUrl":null,"PlayerUrlReason":null,"PrimaryCategory":"","PrimaryCategory_keys":"","PrimaryMediaItemId":null,"PrimaryMediaItemKey":null,"RuleStatus":"Complete","SearchResultBody":"MG11. Meet the Editor-in-Chief of Molecular Cancer Therapeutics: Beverly A. Teicher, PhD","SearchResultCalendarDisplayBlock":null,"SearchResultFooter":"AACR Publications Booth 2101, Exhibit Halls D-H","SearchResultHeader":"Apr 12 2022  9:30AM","SecondaryCategory":"","SecondaryCategory_keys":"","ShowChatLink":null,"Start":"4\/12\/2022 9:30:00 AM","StartTime":"09:30","Status":"Active","StreamingConfiguration":null,"StreamingKey":null,"ThumbnailUrl":null,"Title":"Meet the Editor-in-Chief of Molecular Cancer Therapeutics: Beverly A. Teicher, PhD","Type":null,"TypeKey":null}